Harvard Bioscience Research and Development Expenses 2010-2023 | HBIO

Harvard Bioscience research and development expenses from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
Harvard Bioscience Annual Research and Development Expenses
(Millions of US $)
2023 $12
2022 $12
2021 $11
2020 $9
2019 $11
2018 $11
2017 $6
2016 $5
2015 $6
2014 $5
2013 $4
2012 $4
2011 $4
2010 $5
2009 $4
Harvard Bioscience Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31 $3
2023-09-30 $3
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $3
2022-06-30 $3
2022-03-31 $3
2021-12-31 $3
2021-09-30 $3
2021-06-30 $3
2021-03-31 $2
2020-12-31 $2
2020-09-30 $2
2020-06-30 $2
2020-03-31 $2
2019-12-31 $3
2019-09-30 $3
2019-06-30 $3
2019-03-31 $3
2018-12-31 $3
2018-09-30 $3
2018-06-30 $3
2018-03-31 $2
2017-12-31 $2
2017-09-30 $2
2017-06-30 $1
2017-03-31 $1
2016-12-31 $1
2016-09-30 $1
2016-06-30 $2
2016-03-31 $1
2015-12-31 $2
2015-09-30 $1
2015-06-30 $2
2015-03-31 $2
2014-12-31 $2
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31 $1
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $-1
2012-09-30 $2
2012-06-30 $2
2012-03-31 $2
2011-12-31 $-0
2011-09-30 $2
2011-06-30 $1
2011-03-31 $1
2010-12-31 $1
2010-09-30 $1
2010-06-30 $1
2010-03-31 $1
2009-12-31 $1
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.149B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $31.954B 39.08
Bruker (BRKR) United States $10.998B 30.64
Kewaunee Scientific (KEQU) United States $0.119B 14.09